Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews, research articles and letters written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Current Pharmaceutical Biotechnology is excelling in impact to be the number one journal in its field.

p

Articles from the journal Current Pharmaceutical Biotechnology, Volume 17 Issue 7:

  • Editorial (Thematic Issue: Metabolic Syndrome in Pregnancy)
  • Nature and Nurture in the Early-Life Origins of Metabolic Syndrome
  • Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders
  • Incretins, Pregnancy, and Gestational Diabetes
  • An Interplay between Obesity and Inflammation in Gestational Diabetes Mellitus
  • Nutraceuticals as Lipid-Lowering Treatment in Pregnancy and Their Effects on the Metabolic Syndrome
  • A Prevention of Pre-eclampsia with the Use of Acetylsalicylic Acid and Low-molecular Weight Heparin – Molecular Mechanisms
  • Alkaloids Pharmacological Activities – Prospects for the Development of Phytopharmaceuticals for Neurodegenerative Diseases
  • Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma
  • Biopharmaceutical Potential of Two Ramalina Lichens and their Metabolites

For details on the articles, please visit this link :: http://bit.ly/28gMfjE